Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2006

01-05-2006 | Letter to the Editor

Methotrexate-Associated Lymphoproliferative Disorder Mimicking Composite Lymphoma

Authors: Jun-ichiro Ikeda, Eiichi Morii, Yasuhiko Tomita, Jing-Xian Xu, Hayato Kimura, Masaharu Kohara, Yoshihiko Hoshida, Katsuyuki Aozasa

Published in: International Journal of Hematology | Issue 4/2006

Login to get access
Metadata
Title
Methotrexate-Associated Lymphoproliferative Disorder Mimicking Composite Lymphoma
Authors
Jun-ichiro Ikeda
Eiichi Morii
Yasuhiko Tomita
Jing-Xian Xu
Hayato Kimura
Masaharu Kohara
Yoshihiko Hoshida
Katsuyuki Aozasa
Publication date
01-05-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.05181

Other articles of this Issue 4/2006

International Journal of Hematology 4/2006 Go to the issue

Case Report

Loss of O 6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma

Progress in Hematology

The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors

Letter to the Editor

Bernard-Soulier Syndrome due to GPIX W127X Mutation in Japan Is Frequently Misdiagnosed as Idiopathic Thrombocytopenic Purpura

Case Report

Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor

Case Report

Early-Onset Thyrotoxicosis after Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia

Case Report

Antibody Responses Associated with the Graft-versus-Leukemia Effect in Adult T-Cell Leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits